norfloxacin has been researched along with oxacillin in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.68) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 21 (67.74) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Appendino, G; Giana, A; Gibbons, S; Grassi, G; Pagani, A; Rahman, MM; Smith, E; Stavri, M | 1 |
| Bhakta, S; Boshoff, HI; Evangelopoulos, D; Gibbons, S; Gunaratnam, M; Lenaerts, A; Malkinson, JP; Moreira, JB; Neidle, S; O'Donnell, G; Poeschl, R; Zimhony, O | 1 |
| Chen, ZH; Piao, HR; Sun, LP; Zheng, CJ | 1 |
| Liu, XF; Liu, XK; Piao, HR; Sun, LP; Zheng, CJ | 1 |
| Curry, J; Gibbons, S; Malkinson, JP; Rahman, MM; Shiu, WK; Stapleton, P; Zloh, M | 1 |
| Miao, J; Piao, HR; Sun, LP; Xu, LL; Zheng, CJ | 2 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Deng, XQ; Hou, SP; Liu, TT; Piao, HR; Song, MX; Wang, Q; Xing, XL; Zheng, CJ | 1 |
| Jin, X; Li, YJ; Piao, HR; Song, MX; Sun, LP; Wu, Y; Yu, LJ; Zheng, CJ | 1 |
| Hong, L; Piao, HR; Song, MX; Sun, LP; Wu, Y; Zheng, CJ | 1 |
| Deng, XQ; Hong, L; Jin, MJ; Li, YJ; Liu, Y; Piao, HR; Song, MX; Sun, LP; Wei, ZY; Wu, Y; Zheng, CJ | 1 |
| Guo, M; Li, YJ; Liu, Y; Piao, HR; Song, MX; Sun, LP; Wu, Y; Zheng, CJ | 1 |
| Hou, SP; Li, YR; Liu, JC; Ma, LX; Piao, HR; Wang, MX; Zheng, CJ | 1 |
| Guo, M; Li, C; Li, YR; Liu, JC; Piao, HR; Sun, LP; Zhang, TY; Zheng, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chi, KQ; Liu, HY; Piao, HR; Sun, LP; Wei, ZY; Yu, ZK; Zheng, CJ | 1 |
| Cheng, H; Deng, X; Fu, Z; Liang, Z; Song, M; Wang, S; Wang, Z; Zhou, S | 1 |
| Piao, HR; Sun, LP; Wu, J; Zhang, TY; Zheng, CJ | 1 |
| Du, H; Li, J; Liu, H; Piao, H; Sun, D; Sun, L; Zheng, C | 1 |
| Majik, MS; Rodrigues, L; Tilve, SG | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Benvenisty, A; Fox, CL; Modak, SM; Nowygrod, R; Reemstmau, K; Sampath, L | 1 |
| Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
| Ayers, LW; Barnishan, J; Fass, RJ | 1 |
| Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
| Joung, DK; Kang, OH; Kim, SB; Kim, YC; Kim, YS; Kweon, KT; Kwon, DY; Lee, DS; Mun, SH; Seo, YS; Shin, DW | 1 |
| Li, C; Li, YR; Liu, JC; Piao, HR; Wei, ZY; Zhang, W; Zheng, CJ | 1 |
3 review(s) available for norfloxacin and oxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Synthetic access to thiolane-based therapeutics and biological activity studies.
Topics: Alkaloids; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Biological Products; Cell Survival; Fungi; Humans; Sesquiterpenes; Sulfhydryl Compounds | 2021 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
28 other study(ies) available for norfloxacin and oxacillin
| Article | Year |
|---|---|
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
Topics: Acetylation; Anti-Bacterial Agents; Cannabinoids; Cannabis; Magnetic Resonance Spectroscopy; Methicillin Resistance; Methylation; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Structure-Activity Relationship | 2008 |
Bioactive pyridine-N-oxide disulfides from Allium stipitatum.
Topics: 2,2'-Dipyridyl; Alkaloids; Allium; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Disulfides; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heat-Shock Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Molecular Structure; Oxyquinoline; Pyridines; Thioredoxins; Vitamin K 3 | 2009 |
Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity.
Topics: Anti-Bacterial Agents; Chalcone; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Rhodanine; Staphylococcus; Stereoisomerism; Structure-Activity Relationship | 2010 |
Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Infections; Benzoic Acid; Cell Proliferation; Chalcone; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Staphylococcus aureus; Thiazolidinediones | 2011 |
Antibacterial acylphloroglucinols from Hypericum olympicum.
Topics: Anti-Bacterial Agents; Hypericum; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phloroglucinol; Staphylococcus aureus | 2012 |
Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Fatty Acids; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Rhodanine; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2012 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Drug Resistance, Multiple; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Rhodanine | 2012 |
Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone.
Topics: Anti-Bacterial Agents; Chalcone; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Phenylalanine; Rhodanine; Staphylococcus aureus; Structure-Activity Relationship; Thiazolidines; Thiobarbiturates | 2012 |
Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.
Topics: Aldehydes; Anti-Bacterial Agents; Cell Survival; Drug Resistance, Bacterial; Escherichia coli; HeLa Cells; Humans; Microbial Sensitivity Tests; Pyrazoles; Rhodanine; Staphylococcus aureus; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Phenylalanine; Pyrazoles; Rhodanine; Staphylococcus aureus; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.
Topics: Anti-Bacterial Agents; Cell Survival; Drug Resistance, Multiple, Bacterial; Escherichia coli; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolines; Rhodanine; Structure-Activity Relationship | 2013 |
Synthesis and evaluation of the antimicrobial activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one derivatives.
Topics: Anti-Infective Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Infrared; Thiazolidines | 2014 |
Synthesis and biological evaluation of 1,3-diaryl pyrazole derivatives as potential antibacterial and anti-inflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Drug Resistance, Multiple, Bacterial; Furans; Gram-Negative Bacteria; Gram-Positive Cocci; Ibuprofen; Indomethacin; Mice; Pyrazoles | 2015 |
Synthesis and biological evaluation of chalcone derivatives containing aminoguanidine or acylhydrazone moieties.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Cell Line; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Guanidines; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Salmonella typhimurium; Structure-Activity Relationship | 2016 |
Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Guanidines; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Semicarbazides; Structure-Activity Relationship | 2019 |
Synthesis of novel dihydrotriazine derivatives bearing 1,3-diaryl pyrazole moieties as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Line; Cell Survival; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2019 |
Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rhodanine; Structure-Activity Relationship; Tryptophan | 2019 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
A new method for the direct incorporation of antibiotic in prosthetic vascular grafts.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Vessel Prosthesis; Cerium; Methods; Norfloxacin; Oxacillin; Polyethylene Terephthalates; Polytetrafluoroethylene; Rats; Rats, Inbred Strains; Silver; Sulfadiazine; Zinc | 1987 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Penicillins; Thienamycins | 1995 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Curcuma; Curcumin; Drug Synergism; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Plant Extracts; Rhizome; Time Factors | 2013 |
Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Candida albicans; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Oxacillin; Pyrazoles; Stereoisomerism; Streptococcus mutans; Thiohydantoins | 2016 |